MPC1 and MPC2 expressions are associated with favorable clinical outcomes in prostate cancer
Xiaoli Li(Fujian Medical University), Zhenhe Suo(Oslo University Hospital), Yaqing Li(Shenyang Pharmaceutical University), Yasai Ji(First Affiliated Hospital of Zhengzhou University), Zhirui Fan(First Affiliated Hospital of Zhengzhou University), Mingzhi Zhang(Chinese Academy of Sciences), Gaoyang Han(First Affiliated Hospital of Xinxiang Medical University), Jianguo Wen(Argonne National Laboratory), Xiaoran Li(Shanghai Jiao Tong University), Jing Cao(Third Affiliated Hospital of Zhengzhou University), Jing Zhao(Gansu Provincial Hospital), Jahn M. Nesland(Oslo University Hospital), Yali Zhong(Oslo University Hospital), Mariusz Adam Goscinski(Oslo University Hospital)
Cited by 48
Related Papers
5-Aminolevulinic acid-based photodynamic therapy
|Cancer|1997|976
Roles of circRNAs in the tumour microenvironment
|Molecular Cancer|2020|281
Correlation of Subcellular and Intratumoral Photosensitizer Localization with Ultrastructural Features After Photodynamic Therapy
|Ultrastructural Pathology|1996|214
The Physiologic Role of CD19 Cytoplasmic Tyrosines
|Immunity|2002|145
MiR-103a-3p promotes tumour glycolysis in colorectal cancer via hippo/YAP1/HIF1A axis
|Journal of Experimental & Clinical Cancer Research|2020|139